Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
Identification of targetable molecular changes is essential for selecting appropriate treatment in patients with advanced lung adenocarcinoma. <i>Methods</i>: In this study, a Sanger sequencing plus Fluorescence In Situ Hybridization (FISH) sequential approach was compared with a Next-Ge...
Main Authors: | Maria Gabriela O. Fernandes, Maria Jacob, Natália Martins, Conceição Souto Moura, Susana Guimarães, Joana Pereira Reis, Ana Justino, Maria João Pina, Luís Cirnes, Catarina Sousa, Josué Pinto, José Agostinho Marques, José Carlos Machado, Venceslau Hespanhol, José Luis Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1229 |
Similar Items
-
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
by: Maria Gabriela O. Fernandes, et al.
Published: (2021-05-01) -
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
by: Maria Gabriela O. Fernandes, et al.
Published: (2021-07-01) -
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
by: Maria Gabriela O. Fernandes, et al.
Published: (2021-05-01) -
Paving the Way to Unveil the Diversity and Evolution of Phage Genomes
by: Alejandro Reyes, et al.
Published: (2020-08-01) -
Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel
by: Marta Vives-Usano, et al.
Published: (2021-05-01)